{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T13:06:29Z","timestamp":1794834389254,"version":"4.9.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:00:00Z","timestamp":1705017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:00:00Z","timestamp":1705017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2022YFC2502700"],"award-info":[{"award-number":["2022YFC2502700"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2022YFC25022701"],"award-info":[{"award-number":["2022YFC25022701"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2022YFC2502702"],"award-info":[{"award-number":["2022YFC2502702"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170119"],"award-info":[{"award-number":["82170119"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012524","name":"American Lebanese Syrian Associated Charities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012524","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004610","name":"Science and Technology Support Program of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20210714"],"award-info":[{"award-number":["BK20210714"]}],"id":[{"id":"10.13039\/501100004610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004610","name":"Science and Technology Support Program of Jiangsu Province","doi-asserted-by":"publisher","award":["JSSCBS20210692"],"award-info":[{"award-number":["JSSCBS20210692"]}],"id":[{"id":"10.13039\/501100004610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022944","name":"Suzhou Gusu Medical Youth Talent","doi-asserted-by":"publisher","award":["ZXL2022443"],"award-info":[{"award-number":["ZXL2022443"]}],"id":[{"id":"10.13039\/100022944","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genome Biol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The oncogenic protein HOXA9 plays a critical role in leukemia transformation and maintenance, and its aberrant expression is a hallmark of most aggressive acute leukemia. Although inhibiting the upstream regulators of HOXA9 has been proven as a significant therapeutic intervention, the comprehensive regulation network controlling HOXA9 expression in leukemia has not been systematically investigated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Here, we perform genome-wide CRISPR\/Cas9 screening in the HOXA9-driven reporter acute leukemia cells. We identify a poorly characterized RNA-binding protein, RBM5, as the top candidate gene required to maintain leukemia cell fitness. RBM5 is highly overexpressed in acute myeloid leukemia (AML) patients compared to healthy individuals. RBM5 loss triggered by CRISPR knockout and shRNA knockdown significantly impairs leukemia maintenance in vitro and in vivo. Through domain CRISPR screening, we reveal that RBM5 functions through a noncanonical transcriptional regulation circuitry rather than RNA splicing, such an effect depending on DNA-binding domains. By integrative analysis and functional assays, we identify HOXA9 as the downstream target of RBM5. Ectopic expression of HOXA9 rescues impaired leukemia cell proliferation upon RBM5 loss. Importantly, acute protein degradation of RBM5 through auxin-inducible degron system immediately reduces HOXA9 transcription.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We identify RBM5 as a new upstream regulator of HOXA9 and reveal its essential role in controlling the survival of AML. These functional and molecular mechanisms further support RBM5 as a promising therapeutic target for myeloid leukemia treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13059-023-03149-8","type":"journal-article","created":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T04:02:36Z","timestamp":1705032156000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["RNA-binding protein RBM5 plays an essential role in acute myeloid leukemia by activating the oncogenic protein HOXA9"],"prefix":"10.1186","volume":"25","author":[{"given":"Mengli","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Hyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingcai","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinfeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaela","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Rosikiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beisi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liusheng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Ping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Depei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiqiu","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5938-5510","authenticated-orcid":false,"given":"Chunliang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,12]]},"reference":[{"key":"3149_CR1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41408-021-00425-3","volume":"11","author":"H Kantarjian","year":"2021","unstructured":"Kantarjian H, Kadia T, DiNardo C, Daver N, Borthakur G, Jabbour E, et al. Acute myeloid leukemia: current progress and future directions. Blood Cancer J. 2021;11:41.","journal-title":"Blood Cancer J"},{"key":"3149_CR2","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/S0140-6736(18)31041-9","volume":"392","author":"NJ Short","year":"2018","unstructured":"Short NJ, Rytting ME, Cortes JE. Acute myeloid leukaemia. Lancet. 2018;392:593\u2013606.","journal-title":"Lancet"},{"key":"3149_CR3","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ccell.2019.06.003","volume":"36","author":"I Baccelli","year":"2019","unstructured":"Baccelli I, Gareau Y, Lehnertz B, Gingras S, Spinella J-F, Corneau S, et al. Mubritinib targets the electron transport chain complex I and reveals the landscape of OXPHOS dependency in acute myeloid leukemia. Cancer Cell. 2019;36:84\u201399.e8.","journal-title":"Cancer Cell"},{"key":"3149_CR4","doi-asserted-by":"publisher","first-page":"837","DOI":"10.3390\/cancers11060837","volume":"11","author":"M Lambert","year":"2019","unstructured":"Lambert M, Alioui M, Jambon S, Depauw S, Van Seuningen I, David-Cordonnier MH. Direct and indirect targeting of HOXA9 transcription factor in acute myeloid leukemia. Cancers (Basel). 2019;11:837.","journal-title":"Cancers (Basel)."},{"key":"3149_CR5","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1097\/MOH.0000000000000245","volume":"23","author":"CT Collins","year":"2016","unstructured":"Collins CT, Hess JL. Deregulation of the HOXA9\/MEIS1 axis in acute leukemia. Curr Opin Hematol. 2016;23:354\u201361.","journal-title":"Curr Opin Hematol"},{"key":"3149_CR6","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1101\/gad.1111603","volume":"17","author":"PM Ayton","year":"2003","unstructured":"Ayton PM, Cleary ML. Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9. Genes Dev. 2003;17:2298\u2013307.","journal-title":"Genes Dev"},{"key":"3149_CR7","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.1182\/blood-2009-04-216606","volume":"115","author":"C Bach","year":"2010","unstructured":"Bach C, Buhl S, Mueller D, Garc\u00eda-Cu\u00e9llar M-P, Maethner E, Slany RK. Leukemogenic transformation by HOXA cluster genes. Blood. 2010;115:2910\u20138.","journal-title":"Blood"},{"key":"3149_CR8","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/febs.16268","volume":"290","author":"S Aryal","year":"2023","unstructured":"Aryal S, Zhang Y, Wren S, Li C, Lu R. Molecular regulators of HOXA9 in acute myeloid leukemia. FEBS J. 2023;290:321\u201339.","journal-title":"FEBS J"},{"key":"3149_CR9","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.cell.2005.09.025","volume":"123","author":"A Yokoyama","year":"2005","unstructured":"Yokoyama A, Somervaille TCP, Smith KS, Rozenblatt-Rosen O, Meyerson M, Cleary ML. The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis. Cell. 2005;123:207\u201318.","journal-title":"Cell"},{"key":"3149_CR10","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/MOH.0000000000000123","volume":"22","author":"EM Stein","year":"2015","unstructured":"Stein EM, Tallman MS. Mixed lineage rearranged leukaemia. Curr Opin Hematol. 2015;22:92\u20136.","journal-title":"Curr Opin Hematol"},{"key":"3149_CR11","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nm.3832","volume":"21","author":"C-W Chen","year":"2015","unstructured":"Chen C-W, Koche RP, Sinha AU, Deshpande AJ, Zhu N, Eng R, et al. DOT1L inhibits SIRT1-mediated epigenetic silencing to maintain leukemic gene expression in MLL-rearranged leukemia. Nat Med. 2015;21:335\u201343.","journal-title":"Nat Med"},{"key":"3149_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.57858","volume":"9","author":"H Zhang","year":"2020","unstructured":"Zhang H, Zhang Y, Zhou X, Wright S, Hyle J, Zhao L, et al. Functional interrogation of HOXA9 regulome in MLLr leukemia via reporter-based CRISPR\/Cas9 screen. Elife. 2020;9:1\u201330.","journal-title":"Elife"},{"key":"3149_CR13","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nrm2178","volume":"8","author":"BM Lunde","year":"2007","unstructured":"Lunde BM, Moore C, Varani G. RNA-binding proteins: modular design for efficient function. Nat Rev Mol Cell Biol. 2007;8:479\u201390.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3149_CR14","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/s43018-021-00220-w","volume":"2","author":"C Prieto","year":"2021","unstructured":"Prieto C, Nguyen DTT, Liu Z, Wheat J, Perez A, Gourkanti S, et al. Transcriptional control of CBX5 by the RNA-binding proteins RBMX and RBMXL1 maintains chromatin state in myeloid leukemia. Nat Cancer. 2021;2:741\u201357.","journal-title":"Nat Cancer"},{"key":"3149_CR15","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s43018-020-0054-2","volume":"1","author":"J Bajaj","year":"2020","unstructured":"Bajaj J, Hamilton M, Shima Y, Chambers K, Spinler K, Van Nostrand EL, et al. An in vivo genome-wide CRISPR screen identifies the RNA-binding protein Staufen2 as a key regulator of myeloid leukemia. Nat Cancer. 2020;1:410\u201322.","journal-title":"Nat Cancer"},{"key":"3149_CR16","doi-asserted-by":"publisher","first-page":"3833","DOI":"10.1038\/s41467-022-31155-0","volume":"13","author":"L Liu","year":"2022","unstructured":"Liu L, Vujovic A, Deshpande NP, Sathe S, Anande G, Chen HTT, et al. The splicing factor RBM17 drives leukemic stem cell maintenance by evading nonsense-mediated decay of pro-leukemic factors. Nat Commun. 2022;13:3833.","journal-title":"Nat Commun"},{"key":"3149_CR17","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/ng.3854","volume":"49","author":"LP Vu","year":"2017","unstructured":"Vu LP, Prieto C, Amin EM, Chhangawala S, Krivtsov A, Calvo-Vidal MN, et al. Functional screen of MSI2 interactors identifies an essential role for SYNCRIP in myeloid leukemia stem cells. Nat Genet. 2017;49:866\u201375.","journal-title":"Nat Genet"},{"key":"3149_CR18","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ccell.2019.01.010","volume":"35","author":"E Wang","year":"2019","unstructured":"Wang E, Lu SX, Pastore A, Chen X, Imig J, Chun-Wei Lee S, et al. Targeting an RNA-binding protein network in acute myeloid leukemia. Cancer Cell. 2019;35:369\u2013384.e7.","journal-title":"Cancer Cell"},{"key":"3149_CR19","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.stem.2020.12.005","volume":"28","author":"E Wang","year":"2021","unstructured":"Wang E, Zhou H, Nadorp B, Cayanan G, Chen X, Yeaton AH, et al. Surface antigen-guided CRISPR screens identify regulators of myeloid leukemia differentiation. Cell Stem Cell. 2021;28:718\u2013731.e6.","journal-title":"Cell Stem Cell"},{"key":"3149_CR20","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1002\/cncr.31398","volume":"124","author":"R Assi","year":"2018","unstructured":"Assi R, Kantarjian HM, Kadia TM, Pemmaraju N, Jabbour E, Jain N, et al. Final results of a phase 2, open-label study of indisulam, idarubicin, and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome. Cancer. 2018;124:2758\u201365.","journal-title":"Cancer"},{"key":"3149_CR21","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1038\/s41375-020-0729-9","volume":"34","author":"D Hsiehchen","year":"2020","unstructured":"Hsiehchen D, Goralski M, Kim J, Xie Y, Nijhawan D. Biomarkers for RBM39 degradation in acute myeloid leukemia. Leukemia. 2020;34:1924\u20138.","journal-title":"Leukemia"},{"key":"3149_CR22","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.cell.2009.02.011","volume":"136","author":"TA Cooper","year":"2009","unstructured":"Cooper TA, Wan L, Dreyfuss G. RNA and disease. Cell. 2009;136:777\u201393.","journal-title":"Cell"},{"key":"3149_CR23","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.trecan.2017.05.003","volume":"3","author":"B Pereira","year":"2017","unstructured":"Pereira B, Billaud M, Almeida R. RNA-binding proteins in cancer: old players and new actors. Trends in Cancer. 2017;3:506\u201328.","journal-title":"Trends in Cancer"},{"key":"3149_CR24","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.tig.2008.05.004","volume":"24","author":"KE Lukong","year":"2008","unstructured":"Lukong KE, Chang K, Khandjian EW, Richard S. RNA-binding proteins in human genetic disease. Trends Genet. 2008;24:416\u201325.","journal-title":"Trends Genet"},{"key":"3149_CR25","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/s41375-020-01066-4","volume":"35","author":"IA Elcheva","year":"2021","unstructured":"Elcheva IA, Spiegelman VS. Targeting RNA-binding proteins in acute and chronic leukemia. Leukemia. 2021;35:360\u201376.","journal-title":"Leukemia"},{"key":"3149_CR26","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1097\/JTO.0b013e3181c6e330","volume":"5","author":"LC Sutherland","year":"2010","unstructured":"Sutherland LC, Wang K, Robinson AG. RBM5 as a putative tumor suppressor gene for lung cancer. J Thorac Oncol. 2010;5:294\u20138.","journal-title":"J Thorac Oncol"},{"key":"3149_CR27","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.molcel.2013.11.010","volume":"52","author":"EG Bechara","year":"2013","unstructured":"Bechara EG, Sebesty\u00e9n E, Bernardis I, Eyras E, Valc\u00e1rcel J. RBM5, 6, and 10 differentially regulate NUMB alternative splicing to control cancer cell proliferation. Mol Cell. 2013;52:720\u201333.","journal-title":"Mol Cell"},{"key":"3149_CR28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41419-022-04536-y","volume":"13","author":"X Li","year":"2022","unstructured":"Li X, Yang J, Ni R, Chen J, Zhou Y, Song H, et al. Hypoxia-induced lncRNA RBM5-AS1 promotes tumorigenesis via activating Wnt\/\u03b2-catenin signaling in breast cancer. Cell Death Dis. 2022;13:95.","journal-title":"Cell Death Dis"},{"key":"3149_CR29","doi-asserted-by":"publisher","first-page":"5615","DOI":"10.1158\/0008-5472.CAN-15-1824","volume":"76","author":"CS Di","year":"2016","unstructured":"Di CS, Zhang F, Sancho A, Li S, Aguilo F, Sun Y, et al. RBM5-AS1 is critical for self-renewal of colon cancer stem-like cells. Cancer Res. 2016;76:5615\u201327.","journal-title":"Cancer Res"},{"key":"3149_CR30","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/MOH.0000000000000632","volume":"28","author":"JW Figg","year":"2021","unstructured":"Figg JW, Barajas JM, Obeng EA. Therapeutic approaches targeting splicing factor mutations in myelodysplastic syndromes and acute myeloid leukemia. Curr Opin Hematol. 2021;28:73\u20139.","journal-title":"Curr Opin Hematol"},{"key":"3149_CR31","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","volume":"368","author":"TJ Ley","year":"2013","unstructured":"Ley TJ, Miller C, Ding L, Raphael BJ, Mungall AJ, Robertson A, et al. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013;368:2059\u201374.","journal-title":"N Engl J Med."},{"key":"3149_CR32","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1158\/2159-8290.CD-20-1230","volume":"11","author":"C McLeod","year":"2021","unstructured":"McLeod C, Gout AM, Zhou X, Thrasher A, Rahbarinia D, Brady SW, et al. St. Jude Cloud: a pediatric cancer genomic data-sharing ecosystem. Cancer Discov. 2021;11:1082\u201399.","journal-title":"Cancer Discov."},{"key":"3149_CR33","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1182\/blood.2022016033","volume":"140","author":"MH Kramer","year":"2022","unstructured":"Kramer MH, Zhang Q, Sprung R, Day RB, Erdmann-Gilmore P, Li Y, et al. Proteomic and phosphoproteomic landscapes of acute myeloid leukemia. Blood. 2022;140:1533\u201348.","journal-title":"Blood"},{"key":"3149_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2015.37","volume":"4","author":"X-H Zhang","year":"2015","unstructured":"Zhang X-H, Tee LY, Wang X-G, Huang Q-S, Yang S-H. Off-target effects in CRISPR\/Cas9-mediated genome engineering. Mol Ther - Nucleic Acids. 2015;4: e264.","journal-title":"Mol Ther - Nucleic Acids"},{"key":"3149_CR35","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596:583\u20139.","journal-title":"Nature"},{"key":"3149_CR36","doi-asserted-by":"publisher","first-page":"4233","DOI":"10.1038\/s41467-023-39961-w","volume":"14","author":"K Soni","year":"2023","unstructured":"Soni K, Jagtap PKA, Mart\u00ednez-Lumbreras S, Bonnal S, Geerlof A, Stehle R, et al. Structural basis for specific RNA recognition by the alternative splicing factor RBM5. Nat Commun. 2023;14:4233.","journal-title":"Nat Commun"},{"key":"3149_CR37","doi-asserted-by":"publisher","first-page":"6667","DOI":"10.1021\/bi300539t","volume":"51","author":"Z Song","year":"2012","unstructured":"Song Z, Wu P, Ji P, Zhang J, Gong Q, Wu J, et al. Solution structure of the second RRM domain of RBM5 and its unusual binding characters for different RNA targets. Biochemistry. 2012;51:6667\u201378.","journal-title":"Biochemistry"},{"key":"3149_CR38","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1002\/cbic.201100582","volume":"12","author":"B Farina","year":"2011","unstructured":"Farina B, Fattorusso R, Pellecchia M. Targeting zinc finger domains with small molecules: solution structure and binding studies of the RanBP2-type zinc finger of RBM5. ChemBioChem. 2011;12:2837\u201345.","journal-title":"ChemBioChem"},{"key":"3149_CR39","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3389\/fnmol.2020.00126","volume":"13","author":"TC Jackson","year":"2020","unstructured":"Jackson TC, Kochanek PM. RNA-binding motif 5 (RBM5) in the CNS\u2014moving beyond cancer to harness RNA splicing to mitigate the consequences of brain injury. Front Mol Neurosci. 2020;13:126.","journal-title":"Front Mol Neurosci"},{"key":"3149_CR40","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.neuroscience.2020.04.024","volume":"440","author":"TC Jackson","year":"2020","unstructured":"Jackson TC, Janesko-Feldman K, Gorse K, Vagni VA, Jackson EK, Kochanek PM. Identification of novel targets of RBM5 in the healthy and injured brain. Neuroscience. 2020;440:299\u2013315.","journal-title":"Neuroscience"},{"key":"3149_CR41","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.molcel.2008.08.008","volume":"32","author":"S Bonnal","year":"2008","unstructured":"Bonnal S, Mart\u00ednez C, F\u00f6rch P, Bachi A, Wilm M, Valc\u00e1rcel J. RBM5\/Luca-15\/H37 regulates Fas alternative splice site pairing after exon definition. Mol Cell. 2008;32:81\u201395.","journal-title":"Mol Cell"},{"key":"3149_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-022-02843-3","volume":"24","author":"J Hyle","year":"2023","unstructured":"Hyle J, Djekidel MN, Williams J, Wright S, Shao Y, Xu B, et al. Auxin-inducible degron 2 system deciphers functions of CTCF domains in transcriptional regulation. Genome Biol. 2023;24:1\u201330.","journal-title":"Genome Biol"},{"key":"3149_CR43","doi-asserted-by":"publisher","first-page":"5701","DOI":"10.1038\/s41467-020-19532-z","volume":"11","author":"A Yesbolatova","year":"2020","unstructured":"Yesbolatova A, Saito Y, Kitamoto N, Makino-Itou H, Ajima R, Nakano R, et al. The auxin-inducible degron 2 technology provides sharp degradation control in yeast, mammalian cells, and mice. Nat Commun. 2020;11:5701.","journal-title":"Nat Commun"},{"key":"3149_CR44","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/nrc1169","volume":"3","author":"DL Stirewalt","year":"2003","unstructured":"Stirewalt DL, Radich JP. The role of FLT3 in haematopoietic malignancies. Nat Rev Cancer. 2003;3:650\u201365.","journal-title":"Nat Rev Cancer"},{"key":"3149_CR45","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1038\/sj.leu.2401905","volume":"14","author":"K-F Tse","year":"2000","unstructured":"Tse K-F, Mukherjee G, Small D. Constitutive activation of FLT3 stimulates multiple intracellular signal transducers and results in transformation. Leukemia. 2000;14:1766\u201376.","journal-title":"Leukemia"},{"key":"3149_CR46","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.ccr.2007.08.031","volume":"12","author":"BH Lee","year":"2007","unstructured":"Lee BH, Tothova Z, Levine RL, Anderson K, Buza-Vidas N, Cullen DE, et al. FLT3 Mutations confer enhanced proliferation and survival properties to multipotent progenitors in a murine model of chronic myelomonocytic leukemia. Cancer Cell. 2007;12:367\u201380.","journal-title":"Cancer Cell"},{"key":"3149_CR47","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1182\/blood-2016-10-745133","volume":"129","author":"LY Lee","year":"2017","unstructured":"Lee LY, Hernandez D, Rajkhowa T, Smith SC, Raman JR, Nguyen B, et al. Preclinical studies of gilteritinib, a next-generation FLT3 inhibitor. Blood. 2017;129:257\u201360.","journal-title":"Blood"},{"key":"3149_CR48","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ccell.2020.04.017","volume":"38","author":"R Su","year":"2020","unstructured":"Su R, Dong L, Li Y, Gao M, Han L, Wunderlich M, et al. Targeting FTO suppresses cancer stem cell maintenance and immune evasion. Cancer Cell. 2020;38:79\u201396.e11.","journal-title":"Cancer Cell"},{"key":"3149_CR49","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.molcel.2020.12.026","volume":"81","author":"Y Qing","year":"2021","unstructured":"Qing Y, Dong L, Gao L, Li C, Li Y, Han L, et al. R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO\/m6A\/PFKP\/LDHB axis. Mol Cell. 2021;81:922\u2013939.e9.","journal-title":"Mol Cell"},{"key":"3149_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.757135","volume":"11","author":"Z Li","year":"2021","unstructured":"Li Z, Guo Q, Zhang J, Fu Z, Wang Y, Wang T, et al. The RNA-binding motif protein family in cancer: friend or foe? Front Oncol. 2021;11: 757135.","journal-title":"Front Oncol"},{"key":"3149_CR51","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ccell.2022.12.002","volume":"41","author":"E Wang","year":"2023","unstructured":"Wang E, Pineda JMB, Kim WJ, Chen S, Bourcier J, Stahl M, et al. Modulation of RNA splicing enhances response to BCL2 inhibition in leukemia. Cancer Cell. 2023;41:164\u2013180.e8.","journal-title":"Cancer Cell"},{"key":"3149_CR52","doi-asserted-by":"publisher","first-page":"e1003628","DOI":"10.1371\/journal.pgen.1003628","volume":"9","author":"MK O\u2019Bryan","year":"2013","unstructured":"O\u2019Bryan MK, Clark BJ, McLaughlin EA, D\u2019Sylva RJ, O\u2019Donnell L, Wilce JA, et al. RBM5 is a male germ cell splicing factor and is required for spermatid differentiation and male fertility. PLoS Genet. 2013;9:e1003628. Barsh GS, editor.","journal-title":"PLoS Genet."},{"key":"3149_CR53","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41420-023-01677-7","volume":"9","author":"K Snyder","year":"2023","unstructured":"Snyder K, Gorse K, Kochanek PM, Jackson TC. Neuronal RBM5 modulates cell signaling responses to traumatic and hypoxic-ischemic injury in a sex-dependent manner. Cell Death Discov. 2023;9:379.","journal-title":"Cell Death Discov"},{"key":"3149_CR54","doi-asserted-by":"publisher","first-page":"4348","DOI":"10.1038\/s41467-023-39936-x","volume":"14","author":"M Mullari","year":"2023","unstructured":"Mullari M, Fossat N, Skotte NH, Asenjo-Martinez A, Humphreys DT, Bukh J, et al. Characterising the RNA-binding protein atlas of the mammalian brain uncovers RBM5 misregulation in mouse models of Huntington\u2019s disease. Nat Commun. 2023;14:4348.","journal-title":"Nat Commun"},{"key":"3149_CR55","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.molcel.2014.12.017","volume":"57","author":"C Davidovich","year":"2015","unstructured":"Davidovich C, Wang X, Cifuentes-Rojas C, Goodrich KJ, Gooding AR, Lee JT, et al. Toward a consensus on the binding specificity and promiscuity of PRC2 for RNA. Mol Cell. 2015;57:552\u20138.","journal-title":"Mol Cell"},{"key":"3149_CR56","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/s13059-021-02508-7","volume":"22","author":"Y Ren","year":"2021","unstructured":"Ren Y, Huo Y, Li W, He M, Liu S, Yang J, et al. A global screening identifies chromatin-enriched RNA-binding proteins and the transcriptional regulatory activity of QKI5 during monocytic differentiation. Genome Biol. 2021;22:290.","journal-title":"Genome Biol"},{"key":"3149_CR57","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.cell.2019.06.001","volume":"178","author":"R Xiao","year":"2019","unstructured":"Xiao R, Chen J-Y, Liang Z, Luo D, Chen G, Lu ZJ, et al. Pervasive chromatin-RNA binding protein interactions enable RNA-based regulation of transcription. Cell. 2019;178:107\u2013121.e18.","journal-title":"Cell"},{"key":"3149_CR58","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/nmeth.3810","volume":"13","author":"EL Van Nostrand","year":"2016","unstructured":"Van Nostrand EL, Pratt GA, Shishkin AA, Gelboin-Burkhart C, Fang MY, Sundararaman B, et al. Robust transcriptome-wide discovery of RNA-binding protein binding sites with enhanced CLIP (eCLIP). Nat Methods. 2016;13:508\u201314.","journal-title":"Nat Methods"},{"key":"3149_CR59","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1182\/blood-2011-03-341081","volume":"119","author":"Y Huang","year":"2012","unstructured":"Huang Y, Sitwala K, Bronstein J, Sanders D, Dandekar M, Collins C, et al. Identification and characterization of Hoxa9 binding sites in hematopoietic cells. Blood. 2012;119:388\u201398.","journal-title":"Blood"},{"key":"3149_CR60","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"3149_CR61","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1186\/s13059-014-0554-4","volume":"15","author":"W Li","year":"2014","unstructured":"Li W, Xu H, Xiao T, Cong L, Love MI, Zhang F, et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR\/Cas9 knockout screens. Genome Biol. 2014;15:554.","journal-title":"Genome Biol"},{"key":"3149_CR62","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44:W90\u20137.","journal-title":"Nucleic Acids Res"},{"key":"3149_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-015-0843-6","volume":"16","author":"W Li","year":"2015","unstructured":"Li W, K\u00f6ster J, Xu H, Chen CH, Xiao T, Liu JS, et al. Quality control, modeling, and visualization of CRISPR screens with MAGeCK-VISPR. Genome Biol. 2015;16:1\u201313.","journal-title":"Genome Biol"},{"key":"3149_CR64","doi-asserted-by":"crossref","unstructured":"Zhang M, Hyle J, Chen X, Xin Y, Jin Y, Zhang J, Yang X, Chen X, Wright S, Liu Z, Rosikiewicz W, Xu B, He L, Liu H, Ping N, Wu D, Wen F, Li C, Xu P. RNA-binding protein RBM5 plays an essential role in acute myeloid leukemia by activating the oncogenic protein HOXA9. Available from: https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE225633. (2023).","DOI":"10.1182\/blood-2023-182595"},{"key":"3149_CR65","doi-asserted-by":"publisher","unstructured":"Xu B, Mohamed ND. 2022. RNAseq Figshare. https:\/\/doi.org\/10.6084\/m9.figshare.c.6186670.","DOI":"10.6084\/m9.figshare.c.6186670"}],"container-title":["Genome Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13059-023-03149-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13059-023-03149-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13059-023-03149-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T05:05:41Z","timestamp":1705035941000},"score":1,"resource":{"primary":{"URL":"https:\/\/genomebiology.biomedcentral.com\/articles\/10.1186\/s13059-023-03149-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,12]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3149"],"URL":"https:\/\/doi.org\/10.1186\/s13059-023-03149-8","relation":{},"ISSN":["1474-760X"],"issn-type":[{"value":"1474-760X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,12]]},"assertion":[{"value":"12 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the primary cells of five AML patients and three healthy donors were from Hematologic Biobank, National Clinical Research Center for Hematologic Diseases, Jiangsu Provincial Science and Technology Resources (Clinical Resources) Coordination Service Platform, and The First Affiliated Hospital of Soochow University. The informed consent forms were approved by the Ethics Committee of Soochow University and The First Affiliated Hospital of Soochow University (ID: 2017169\u20133, Suzhou, China), in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Wenjing She was the primary editor of this article and managed its editorial process and peer review in collaboration with the rest of the editorial team.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Peer review information"}},{"value":"Dr. Chunliang Li is an editorial board member for <i>Genome Biology<\/i>. The other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16"}}